PLGA, PLA, PCL polymers for Controlled Drug Delivery

Introduction: Peptide Acylation Impurity Analysis is the targeted detection, identification and, where possible, quantitation of peptide variants carrying unwanted acyl […]

Introduction: PLGA Molecular Weight and End-Group Chemistry together determine how quickly a PLGA matrix hydrolyzes and how a drug moves

Introduction: PLA nanoparticles for targeted cancer delivery are nanoscale polymeric carriers in which an anticancer compound is incorporated into biodegradable

Introduction: PLGA molecular weight and drug release are closely connected because polymer chain length controls water penetration, degradation, matrix erosion

Introduction: PLGA and PLA are biodegradable polyester polymers that can be engineered into controlled-release depots — microspheres, nanoparticles, in-situ forming

Introduction: If you work in pharmaceutical formulation, you already know that PLGA in drug delivery isn’t a trend — it’s

Introduction: The development of a PLGA Long-Acting Injectable Formulation for a GLP-1 receptor agonist can provide an important strategy for

Introduction Scaling Poly(lactic-co-glycolic acid) PLGA Microsphere Manufacturing from a 1g laboratory bench batch to a 500g cGMP-compliant pilot scale requires

Introduction Poly(lactic-co-glycolic acid) PLGA Nanoparticle Development offers an advanced biomaterial platform for the encapsulation, stabilization, and delivery of fragile subunit

Introduction Stabilising a Growth Hormone Protein API within poly(lactic-co-glycolic acid) (PLGA) microspheres requires the control of several degradation mechanisms, including